158 related articles for article (PubMed ID: 12906366)
1. Caffeine raises the serum melatonin level in healthy subjects: an indication of melatonin metabolism by cytochrome P450(CYP)1A2.
Ursing C; Wikner J; Brismar K; Röjdmark S
J Endocrinol Invest; 2003 May; 26(5):403-6. PubMed ID: 12906366
[TBL] [Abstract][Full Text] [Related]
2. Does hepatic metabolism of melatonin affect the endogenous serum melatonin level in man?
Ursing C; Härtter S; von Bahr C; Tybring G; Bertilsson L; Röjdmark S
J Endocrinol Invest; 2002 May; 25(5):459-62. PubMed ID: 12035944
[TBL] [Abstract][Full Text] [Related]
3. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-- an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin.
von Bahr C; Ursing C; Yasui N; Tybring G; Bertilsson L; Röjdmark S
Eur J Clin Pharmacol; 2000 May; 56(2):123-7. PubMed ID: 10877005
[TBL] [Abstract][Full Text] [Related]
4. Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: a pilot study.
Härtter S; Ursing C; Morita S; Tybring G; von Bahr C; Christensen M; Röjdmark S; Bertilsson L
Clin Pharmacol Ther; 2001 Jul; 70(1):10-6. PubMed ID: 11452239
[TBL] [Abstract][Full Text] [Related]
5. Influence of cigarette smoking on melatonin levels in man.
Ursing C; von Bahr C; Brismar K; Röjdmark S
Eur J Clin Pharmacol; 2005 May; 61(3):197-201. PubMed ID: 15824912
[TBL] [Abstract][Full Text] [Related]
6. [On the possibility of patient phenotyping on the basis of cytochrome p-450 1A2 isoenzyme activity using caffeine as the test substrate].
Filimonova AA; Ziganshina LE; Ziganshin AU; Chichirov AA
Eksp Klin Farmakol; 2009; 72(5):61-5. PubMed ID: 19928580
[TBL] [Abstract][Full Text] [Related]
7. Dietary effect on mixed function P450 1A2 activity assayed by estimation of caffeine metabolism in man.
Kall MA; Clausen J
Hum Exp Toxicol; 1995 Oct; 14(10):801-7. PubMed ID: 8562120
[TBL] [Abstract][Full Text] [Related]
8. Clinically significant pharmacokinetic interactions between dietary caffeine and medications.
Carrillo JA; Benitez J
Clin Pharmacokinet; 2000 Aug; 39(2):127-53. PubMed ID: 10976659
[TBL] [Abstract][Full Text] [Related]
9. Influence of menthol on caffeine disposition and pharmacodynamics in healthy female volunteers.
Gelal A; Guven H; Balkan D; Artok L; Benowitz NL
Eur J Clin Pharmacol; 2003 Sep; 59(5-6):417-22. PubMed ID: 12915954
[TBL] [Abstract][Full Text] [Related]
10. Absorption and subjective effects of caffeine from coffee, cola and capsules.
Liguori A; Hughes JR; Grass JA
Pharmacol Biochem Behav; 1997 Nov; 58(3):721-6. PubMed ID: 9329065
[TBL] [Abstract][Full Text] [Related]
11. Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects.
Backman JT; Karjalainen MJ; Neuvonen M; Laitila J; Neuvonen PJ
Br J Clin Pharmacol; 2006 Sep; 62(3):345-57. PubMed ID: 16934051
[TBL] [Abstract][Full Text] [Related]
12. Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.
Kinzig-Schippers M; Fuhr U; Zaigler M; Dammeyer J; Rüsing G; Labedzki A; Bulitta J; Sörgel F
Clin Pharmacol Ther; 1999 Mar; 65(3):262-74. PubMed ID: 10096258
[TBL] [Abstract][Full Text] [Related]
13. Nonparametric expectation maximisation (NPEM) population pharmacokinetic analysis of caffeine disposition from sparse data in adult caucasians: systemic caffeine clearance as a biomarker for cytochrome P450 1A2 activity.
Terziivanov D; Bozhinova K; Dimitrova V; Atanasova I
Clin Pharmacokinet; 2003; 42(15):1393-409. PubMed ID: 14674790
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers.
Chen Y; Xiao P; Ou-Yang DS; Fan L; Guo D; Wang YN; Han Y; Tu JH; Zhou G; Huang YF; Zhou HH
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):828-33. PubMed ID: 19215233
[TBL] [Abstract][Full Text] [Related]
15. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking.
Faber MS; Fuhr U
Clin Pharmacol Ther; 2004 Aug; 76(2):178-84. PubMed ID: 15289794
[TBL] [Abstract][Full Text] [Related]
16. Correlation of cytochrome P450 (CYP) 1A2 activity using caffeine phenotyping and olanzapine disposition in healthy volunteers.
Shirley KL; Hon YY; Penzak SR; Lam YW; Spratlin V; Jann MW
Neuropsychopharmacology; 2003 May; 28(5):961-6. PubMed ID: 12644842
[TBL] [Abstract][Full Text] [Related]
17. Variation of CYP1A2-dependent caffeine metabolism during menstrual cycle in healthy women.
Zaigler M; Rietbrock S; Szymanski J; Dericks-Tan JS; Staib AH; Fuhr U
Int J Clin Pharmacol Ther; 2000 May; 38(5):235-44. PubMed ID: 10839467
[TBL] [Abstract][Full Text] [Related]
18. Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeine.
Backman JT; Granfors MT; Neuvonen PJ
Eur J Clin Pharmacol; 2006 Jun; 62(6):451-61. PubMed ID: 16758262
[TBL] [Abstract][Full Text] [Related]
19. A Phase 1 Open-Label, Fixed-Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects.
Thai C; Tayo B; Critchley D
Clin Pharmacol Drug Dev; 2021 Nov; 10(11):1279-1289. PubMed ID: 33951339
[TBL] [Abstract][Full Text] [Related]
20. Plasma melatonin concentration before and during testosterone replacement in Klinefelter's syndrome: relation to hepatic indolamine metabolism and sympathoadrenal activity.
Caglayan S; Ozata M; Ozisik G; Turan M; Bolu E; Oktenli C; Arslan N; Erbil K; Gul D; Ozdemir IC
J Clin Endocrinol Metab; 2001 Feb; 86(2):738-43. PubMed ID: 11158039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
